| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.382 | 11.252 | 12.395 | 25.094 | 42.240 | 32.991 | 46.496 | 87.749 | 115.416 | 163.841 |
| Total Income - EUR | 14.948 | 14.781 | 15.864 | 28.500 | 45.580 | 36.268 | 49.700 | 91.043 | 118.620 | 167.027 |
| Total Expenses - EUR | 14.423 | 14.463 | 15.439 | 5.543 | 5.316 | 22.854 | 18.065 | 24.895 | 37.764 | 39.866 |
| Gross Profit/Loss - EUR | 524 | 318 | 424 | 22.957 | 40.263 | 13.414 | 31.635 | 66.149 | 80.856 | 127.161 |
| Net Profit/Loss - EUR | 183 | 205 | 301 | 22.204 | 38.996 | 12.668 | 30.268 | 63.569 | 79.702 | 122.246 |
| Employees | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Diacavmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 49.261 | 43.541 | 37.681 | 31.949 | 26.393 | 124.339 | 117.212 | 115.430 | 113.690 | 108.097 |
| Current Assets | 508 | 299 | 1.529 | 12.399 | 41.846 | 37.719 | 45.056 | 109.054 | 127.150 | 235.313 |
| Inventories | 99 | 143 | 0 | 0 | 0 | 0 | 57 | 177 | 153 | 278 |
| Receivables | 0 | 0 | 0 | 0 | 40.718 | 14.490 | 33.055 | 67.871 | 61.855 | 134.280 |
| Cash | 408 | 156 | 1.529 | 12.399 | 1.128 | 23.228 | 11.944 | 41.006 | 65.141 | 100.755 |
| Shareholders Funds | 353 | 555 | 846 | 22.366 | 39.155 | 12.824 | 30.420 | 63.722 | 79.854 | 122.398 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.990 | 43.286 | 12.779 | 271 | 11.133 | 134.900 | 121.035 | 153.129 | 156.581 | 219.817 |
| Income in Advance | 33.425 | 29.555 | 25.586 | 21.711 | 17.951 | 14.334 | 10.812 | 7.632 | 4.405 | 1.195 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diacavmed S.r.l.